PCM
VIR icon

Polymer Capital Management’s Vir Biotechnology VIR Stock Holding History

Polymer Capital Management’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-33,565
Closed -$301K – 1001
2026
Q1 		$301K Buy
33,565
+23
+0.1% +$183 0.03% 604
2025
Q4 		$202K Buy
+33,542
New +$200K 0.02% 693
2025
Q2 		– Sell
-43,142
Closed -$280K – 783
2025
Q1 		$280K Buy
43,142
+29,352
+213% +$261K 0.07% 368
2024
Q4 		$101K Buy
+13,790
New +$109K 0.03% 340

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Polymer Capital Management's VIR Position: Q2 2026 in Review

Polymer Capital Management sold out of Vir Biotechnology (VIR) in Q2 2026, closing a stake of 33,565 shares — an estimated $301K sold.

Polymer Capital Management first reported a position in VIR in Q4 2024 and held it in 4 quarters. The position peaked at $301K in Q1 2026. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • Polymer Capital Management reported no remaining Vir Biotechnology position as of Q2 2026 after selling out during the quarter.
  • Polymer Capital Management sold 33,565 Vir Biotechnology shares in Q2 2026, an estimated $301K.
  • Polymer Capital Management first reported a position in Vir Biotechnology in Q4 2024 and held it in 4 quarters.
  • Polymer Capital Management's Vir Biotechnology position peaked at $301K in Q1 2026.
  • 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Polymer Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.